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EVALUATION OF A MODIFIED 
EVISCERATION TECHNIQUE 
INVOLVING TRANS-SCLERAL 
QUADRISECTION AND PMMA 
IMPLANTATION IN NON-INFECTED 
BLIND EYES 
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HISTORY 
 References to ocular surgical procedures predate 2000 BC 
(before the common era). Sumerian law limited what a practitioner 
could charge for successful eye operations; for those procedures 
deemed unsuccessful, the penalty was amputation of the surgeon’s 
hands. In the mid 16th century1, extirpation of the eye was described. 
The disfiguring procedure was more akin to a subtotal exenteration, 
including removal of portions of the conjunctiva, extraocular muscles, 
and orbital fascia. The patient could not be fitted with an ocular 
prosthesis2. In the mid 1800s, O’Ferral and Bonnet developed a more 
accepted technique, which involved transecting the extraocular 
muscles at their scleral insertions and preserving Tenon’s capsule. 
Their description is most consistent with enucleation as we know it 
today. 
 The first description of an evisceration is credited to Beer in 
1817. While he was performing a glaucoma procedure, the eye 
experienced an expulsive hemorrhage and Beer removed the ocular 
contents. In 1874, Noyes published his experience in removing the 
contents of severely infected eyes and it is he who is credited with first 
using evisceration as a routine procedure. 
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 In 1884, Mules placed a glass sphere3 into an eviscerated scleral 
shell, initiating the search for the perfect implant. The early implants 
were hollow glass spheres and had unacceptably high extrusion rates. 
Throughout the early part of the 20th century, numerous implant 
materials were investigated, including gold, silver, vitallium (a cobalt–
chromium alloy), platinum, aluminum, cartilage, bone, fat, fascia lata, 
sponge, wool, rubber, silk, catgut, peat, agar, asbestos, cork, ivory, 
paraffin and cellulose.  
 Concerns about the simple spheres’ tendency to migrate, 
incomplete translation of socket motility to the prosthesis4 and 
inadequate volume replacement led to the development of several 
unique implants. Shape and texture modifications sought to isolate the 
extraocular muscles to their respective quadrants to limit implant 
migration. Anterior implant projections (Figure 1), some with exposed 
coupling pegs5, were engineered to create a direct linkage with the 
prosthesis and maximize motility. Several implants met the goal of 
improved prosthesis motility but at the expense of unacceptably high 
exposure and extrusion rates. Others developed donor sclera6 covering 
techniques (Figure 2) for the acrylic and silicone spheres, historically 
the best tolerated of any implant design, allowing the muscles to be 
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sutured to the implant. The latter technique remains an acceptable 
adjunct to enucleation surgery today, with the same acrylic and silicone 
spheres acceptable as evisceration implants.  
 Since the early to mid 1990s, porous implants7 (hydroxyapatite 
and porous polyethylene) (Figures 3, 4) have become the choice for 
many surgeons. The interconnecting porous channels (Figure 5) allow 
fibrovascular ingrowth throughout the implant. This ingrowth (Figure 
6) stabilizes the implant position and limits migration. After the 
implant has completely fibrovascularized, it may be drilled and an 
anterior projecting coupling peg placed. Although early results of the 
pegging process have been promising, recent reports of complications 
are emerging. The long-term prognosis for drilling of implants and 
placing of pegs is not yet known. 
4 
 
PREOPERATIVE PLANNING 
Decision to Remove the Eye 
 The psychological effect of losing an eye may present greater 
difficulties for the patient than the physical disability. The preoperative 
time spent addressing eye removal, as well as discussing life after 
losing an eye, will reap benefits in postoperative recovery and 
acceptance.  
 Photographs of other anophthalmic patients are useful as the 
prospective patient tries to understand the process. It may be helpful to 
facilitate a meeting between the patient facing eye removal and one 
who has completed the process. Psychiatric referral8 is appropriate for 
patients who manifest increased difficulty coping with the loss. 
Preoperative Counseling 
 It is vitally important that the patient be prepared for surgery and 
the rehabilitation to follow. Pain is variable in the immediate 
postoperative period and patients should be assured that appropriate 
medication will be provided. The patient must be prepared to wear a 
conformer for 5 to 7 weeks until the socket is ready to be fitted with a 
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prosthesis. In addition, the patient must understand that the fitting 
process may require several appointments over as many weeks. 
Goals of Rehabilitating the Anophthalmic Socket 
 Communication between the ophthalmologist and the ocularist is 
integral to a good outcome. The ophthalmologist must select an 
implant of appropriate volume to allow for optimal prosthetic size. Too 
small an implant necessitates an inappropriately large prosthesis to fill 
the orbital volume and this may limit motility and transmit excess 
weight to the lower eyelid. Over time, the excess weight will result in 
laxity of the lower eyelid with a resultant asymmetric appearance. On 
the other hand, too large an implant limits the ocularist’s ability to 
fashion a prosthesis with simulated anterior chamber depth without 
imparting a proptotic appearance to the orbit. 
 The ocularist can modify the prosthesis to adjust lid position, 
correct for a shortened conjunctival culde-sac and improve motility. 
The posterior surface of the prosthesis can be vaulted in cases of 
conjunctival irritation or breakdown. Patients who elect to undergo 
implant pegging to maximize prosthetic motility rely on the 
ophthalmologist and the ocularist to coordinate their care. The ocularist 
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can provide a prosthetic template to assist the ophthalmologist in peg 
placement and centration. Following the peg placement, the ocularist 
will modify the implant to allow implant–prosthetic coupling9. 
 Eye removal and socket rehabilitation are not procedures to 
relegate to minimally supervised junior residents. This is the primary 
procedure that will determine long-term success and promote rapid 
patient rehabilitation. Less than-optimal surgical technique can lead to 
subsequent procedures to address implant exposure, implant extrusion 
(Figure 7), implant migration, socket contraction, chronic pain and lid 
malposition (Figure 8). The same impeccable attention that the 
ophthalmologist commits to microsurgical ocular procedures is 
essential for surgery of the anophthalmic socket. Preservation of 
conjunctiva, implant placement and sizing, anatomical reinsertion of 
extraocular muscles, and tension-free wound closure are integral to a 
successful outcome. 
Decision to Enucleate or Eviscerate 
 The patient needs to understand the available options and to 
participate in the choice between enucleation (removal of the globe 
and a segment of the anterior optic nerve) and evisceration (removal of 
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the ocular contents with preservation of the sclera and in some cases, 
the cornea). The ophthalmologist must guide the patient to the most 
appropriate procedure if absolute indications or contraindications exist. 
Some patients may take comfort in evisceration and equate the 
retention of the scleral shell to keeping the eye. Conversely, the 
appropriately selected evisceration candidate may find the minimal risk 
of sympathetic ophthalmia10 to be unacceptable and elect for 
enucleation. 
 Although a consensus does not exist, most authors agree that 
penetrating trauma11 increases the risk of sympathetic ophthalmia and 
is a contraindication to evisceration. For ocular trauma that leads to 
loss of useful vision, enucleation removes the uveal tissue implicated 
in inciting inflammation in the sympathizing eye12.  
 Otherwise-untreatable intraocular malignancies and cases that 
require histopathological review for assessment of the tumor margins 
dictate enucleation13. In addition, a small, phthisical eye may preclude 
adequate volume replacement following evisceration. 
 
8 
 
 On the other hand, in cases of endophthalmitis, evisceration 
offers a relative barrier to posterior spread of the infection. 
Evisceration may impart less disruption to the orbital tissues, does not 
require disinsertion of the rectus muscles, and may enhance cosmesis. 
In cases appropriate for either procedure, the surgeon should pursue the 
technique that allows for the most consistent results in his or her hands. 
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ENUCLEATION 
 Enucleation involves removing both the globe and a segment of 
the anterior optic nerve, with care taken to preserve the conjunctiva, 
Tenon’s capsule and the extraocular muscles. 
 The indications for enucleation14 include severe trauma, 
intraocular tumors and cases at risk for sympathetic ophthalmia. In the 
setting of eye injury secondary to war wounds, enucleation is more 
commonly the procedure of choice. It is these severe wounds with 
uveal prolapse that are at greater risk for sympathetic ophthalmia and 
early removal of the inciting eye minimizes this risk. The presence of a 
known or suspected ocular tumor that is untreatable by other means 
dictates enucleation over evisceration. In a blind, painful eye with 
opaque media, enucleation is the better choice and precludes the 
possibility of eviscerating an occult tumor.  
 Enucleation surgery15 is best performed under general anesthesia 
but, with a cooperative patient, can successfully be undertaken with a 
retrobulbar anesthetic block alone. An epinephrine-containing 
retrobulbar block is a recommended adjunct to general anesthesia. 
Lidocaine with epinephrine is injected into the perilimbal bulbar 
conjunctiva to promote hemostasis, and the fluid wave assists in 
dissecting the conjunctiva and Tenon’s capsule from the limbal sclera. 
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SURGICAL GOALS OF ENUCLEATION 
AND EVISCERATION 
•  To achieve a centrally placed inert implant with adequate 
anterior coverage. 
•  To achieve appropriate volume replacement in the orbit. 
•  To maintain deep fornices and eyelid support for the placement 
of a prosthesis. 
•  To provide symmetry with the contralateral orbit. 
•  To allow for maximum socket motility, with translation of forces 
to the prosthesis. 
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PROCEDURE OF ENUCLEATION 
 Curved tenotomy or Westcott scissors are used to perform a 
360° limbal peritomy. In an effort to preserve the greatest amount of 
conjunctiva for closure, the tips of the scissors are used to elevate 
Tenon’s capsule and the conjunctiva toward the corneal limbus before 
cutting.  
 Curved Steven’s scissors are then placed into the oblique 
quadrants and slid posteriorly along the sclera. The tips are spread  
and withdrawn to separate Tenon’s capsule from the sclera. The check 
ligaments are then identified by pulling the conjunctiva and Tenon’s 
capsule away from the rectus muscles and the anterior fibers are cut to 
better expose the insertion. Muscle hooks are passed in a serial fashion 
under the muscle to isolate and elevate it. As the toe of the hook 
emerges from under the muscle, it will be covered by a thin film of 
Tenon’s capsule; a small snip in this tissue is necessary to complete the 
pass.  A second muscle hook is passed through this track and the 
muscle insertion is presented for traction suture placement. A double-
armed 6-0 Vicryl (polyglactin) suture with spatulated needles is passed 
through the muscle parallel to and 3 to 5 mm from the muscle 
insertion. A locking bite is secured at each pole of the muscle. The 
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muscle is disinserted from its attachment to the sclera using Westcott 
or tenotomy scissors. This procedure is repeated for each of the four 
rectus muscles. 
  When transecting the medial and lateral rectus, it is advisable to 
leave a small segment of tendon on the globe so that a traction suture 
can be attached to the eye. A 4-0 silk suture is whip-stitched through 
both tendon stumps to make manipulation of the eye easier. This step 
facilitates oblique muscle identification and allows for controlled 
anterior traction as the optic nerve is later transected. 
 Rotating the eye inferiorly and medially allows for identification 
of the superior oblique tendon in the superolateral quadrant. The 
tendon is isolated with a muscle hook and transected at its scleral 
attachment. Next, the eye is rotated superiorly and medially to identify 
the inferior oblique muscle, which is transected free from its insertion 
near the macula. Using silk traction sutures, the eye can be rotated 
about its primary axis to assess freedom of movement. Limitations to 
rotation suggest an incomplete rectus or oblique muscle disinsertion. 
Next, the eye is torted laterally and curved enucleation scissors are 
inserted into the medial orbital space. The tips of the scissors are used 
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to locate the optic nerve by strumming it from above and below. The 
blades of the scissors are then spread to span the nerve. 
 While applying anterior traction to the globe, the scissors are 
slid posteriorly and the optic nerve is transected. An attempt is made to 
take at least a 4-mm segment of nerve with the globe. The eye is 
removed from the socket and any residual soft-tissue attachments are 
transected. Packing material is then placed into the socket for several 
minutes to control bleeding.  
 Sizing spheres may be used to determine an appropriate implant 
size. The implant should provide adequate volume replacement and 
when properly positioned should allow for a tension-free anterior 
closure of Tenon’s capsule and conjunctiva16.  
 The most frequently used implant across the world is porous 
polyethylene,  of  size 20  mm. The implant is placed into the socket 
using a sphere introducer. If an introducer is not available, forceps are 
used in a hand-over-hand fashion to pull Tenon’s capsule up and over 
the implant. 
 Next, the extraocular muscles are attached to the implant. Each 
needle of the double-armed suture, preplaced in the rectus muscles, is 
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passed through the porous polyethylene implant. The needle tip is 
placed into a surface pore and a shallow pass is made through the 
surface material of the implant. As these sutures are pulled tight and 
secured, the muscle becomes firmly attached to the implant in a 
position slightly anterior to the original anatomical placement. This 
positioning helps cover the anterior aspect of the implant and protects 
against its exposure.  
 Each of the four rectus muscles is reattached in this fashion. 
Tenon’s capsule is draped anteriorly to ensure that it will cover the 
implant without tension across the wound. This layer is crucial and 
several layers of interrupted 6-0 Vicryl sutures are used to close it. 
Care is taken to avoid trapping the conjunctiva, which will predispose 
to the development of inclusion cysts. Finally, a running 7-0 Vicryl 
suture closes the conjunctiva. The suture only approximates the 
conjunctival edges and does not add strength to the closure. Sterile 
antibiotic ointment and a plastic conformer are then placed behind the 
eyelids into the interpalpebral forniceal space. The largest conformer 
that allows for closure of the eyelids should be used. A pressure patch 
is applied over the closed eyelids for 48 hours. 
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EVISCERATION 
 The evisceration process removes the ocular contents but 
preserves the sclera and in some cases, the cornea. The goals of 
evisceration and enucleation are the same. Although no firm consensus 
exists on the indications for evisceration, most experts agree that a 
patient with a blind, painful eye without risk of intraocular 
malignancy17 is a good candidate. Additionally, eyes lost to 
endophthalmitis may be best treated with evisceration.  
 Evisceration (Figures 9-15) is best performed under general 
anesthesia supplemented with a retrobulbar block  but may also be 
performed with local retrobulbar anesthesia alone. The conjunctiva is 
injected with an epinephrine-containing local anesthetic mixture before 
the procedure. As described above for enucleation, a limbal peritomy is 
performed. The conjunctiva and Tenon’s capsule are elevated off the 
sclera back to the insertions of the rectus muscle. A partial-thickness 
incision is made around the corneal limbus and scissors are used to 
excise the corneal  button. A cornea-sparing technique has also been 
described. An evisceration spoon is placed into the eye to scoop out the 
intraocular contents. The dissection plane is just internal to the sclera, 
and the entire uveal tract, vitreous, lens, and anterior ocular structures 
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are removed. Sterile, cotton-tipped applicators soaked with absolute 
alcohol solution are used to treat the internal aspect of the sclera, 
minimizing the potential for viable uveal tissue remnants. 
 Small, radial incisions are made in the oblique quadrants of the 
sclera so that sizing spheres can be placed into the scleral shell. Care is 
taken to select an implant that will minimize any anterior traction on 
the scleral closure. An insertion device can be used to place the implant 
into the scleral shell and forceps can be used to further position the 
implant and ensure that it is adequately seated. If the sclera does not 
easily close over the implant, then posterior radial incisions may be 
made in the scleral shell to allow the implant to be placed deeper.  
 A 4-0 nonabsorbable suture (eg, Mersilene) is then used to close 
the sclera over the implant. Tenon’s capsule and the conjunctiva are 
now closed in separate overlying layers. A conformer is placed behind 
the eyelids and a pressure patch is applied for 48 hours. 
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IMPLANTS 
 The most suitable options18 at present include (a) solid spheres, 
(b) autogenous dermis fat grafts (Figure 16) and (c) porous implants. 
 The solid spherical implants, either acrylic 
(polymethylmethacrylate) or silicone, are well tolerated, have low 
extrusion rates and are inexpensive. Their disadvantages include a 
tendency to migrate within the orbit and decreased motility. However, 
by wrapping the implant in donor sclera and reattaching the extraocular 
muscles, it may be possible to minimize both of these complications.  
 The autogenous dermis fat graft is readily available in all 
settings  and the implanted tissue can augment the lining of a 
contracted socket. Disadvantages include decreased motility, 
unpredictable resorption  and increased operative time. Although it 
may not be the primary implant of choice, harvesting and implanting 
the dermis fat graft are procedures that ophthalmologists should be 
prepared to perform.  
 The graft is harvested from an area midway between the anterior 
superior iliac spine and the ipsilateral buttock. The area is injected with 
local anesthetic. A 20-mm circle is drawn and incised to a depth of 
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approximately 20 mm or just above the underlying muscular fascia. 
Before removing this cylindrical core of tissue, the epidermis is sharply 
excised or abraded from the dermis and discarded. The dermis-covered 
fat plug is then separated from its deep attachments and transferred to 
the recipient orbit. The donor site is converted into an ellipse and 
closed primarily. The dermis fat graft is inserted into the orbit. The 
tagged extraocular muscles are drawn up and sutured in correct 
anatomical position to the edge of the dermis cap. Tenon’s capsule and 
the conjunctiva can now be positioned over the edge of the dermis 
graft and sutured into position. By minimizing the overlap at this 
junction, maximal socket surface area is maintained. The bare dermis 
will epithelialize under the conformer. 
 The porous implants are the ones most commonly used today. 
Both hydroxyapatite and porous polyethylene have interconnecting 
pores that provide a passive latticework for fibrovascular ingrowth. 
This ingrowth helps stabilize the implant position within the muscle 
cone and provides the implant with access to the patient’s immune 
system. After fibrovascular ingrowth is complete, an optional pegging 
procedure may be considered, in which the prosthesis is directly 
coupled to the implant, allowing complete translation of socket 
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motility. Many patients, however, are satisfied with the motility of the 
uncoupled prosthesis and decline to risk the potential complications 
associated with the pegging procedure. These complications include 
chronic discharge, peg extrusion and implant exposure.  
 Hydroxyapatite implants must be wrapped prior to placement. 
Donor sclera (Figure 17), readily available from eye banks, is 
commonly used for this purpose. The wrap covers the abrasive surface 
of the implant, decreasing the risk of conjunctival breakdown and 
providing a scaffold to which the extraocular muscles are reattached. 
Four small windows are cut in the sclera to accept each of the four 
rectus muscles. The windows are positioned to approximate the 
anatomical insertion of the extraocular muscles. Each of the double-
armed Vicryl suture needles is passed through the anterior edge of the 
scleral window. Securing these sutures pulls the muscle into the 
window and into contact with the hydroxyapatite implant. This 
provides the anterior implant with a source for fibrovascularization. 
Several windows may be cut in the posterior aspect of the implant 
wrap to accelerate the ingrowth there.  
 Porous polyethylene implants have a smooth surface and may be 
placed without a wrap. The  material is also softer, and the suture 
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needles used to attach the extraocular muscles can be passed through 
the surface of the implant. The curved needle engages the implant in a 
surface pore at a shallow angle. With steady force, the needle is passed 
forward and the natural curve of the needle returns it to the implant 
surface.  
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POSTOPERATIVE CARE 
 The use of systemic antibiotics should be dictated by the 
potential for infection. Routine enucleation or evisceration with 
minimal risk of infection need not be covered with antibiotics. 
 The pressure patch is applied following surgery to preclude 
orbital hematoma formation. It also serves to maintain the conformer in 
position under the eyelids, ensuring the preservation of deep superior 
and inferior fornices. The patch is removed 48 hours after surgery 
unless discharge or patient complaints of increasing orbital pain 
warrant earlier removal to allow inspection of the socket. Following 
removal of the pressure patch, the patient is instructed to instil an 
ophthalmic antibacterial ointment into the interpalpebral fissure twice 
daily for 7 days.  
 The conformer is first removed 1 week following surgery, and a 
careful inspection of the socket is performed. The conjunctival suture 
line is surveyed for breakdown and areas of implant exposure. Any 
indication of infection warrants aggressive management, including 
culture and appropriate antibiotics. The patient is next seen 5 to 6 
weeks following surgery. At that time, the conjunctiva should be pink 
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and free of edema. The superior and inferior  forniceal spaces should 
be deep and there should be no evidence of implant exposure. The 
patient is now ready for referral to the ocularist for socket  evaluation 
and prosthesis fitting.  
 Most patients who receive porous implants are satisfied with the 
translation of socket movement to the prosthesis without pursuing 
direct coupling. The ocularist should be consulted before the option of 
implant pegging is entertained. Changes to the posterior prosthesis—in 
addition to overall size modifications—may provide satisfactory 
improvement in motility. If the patient still desires increased motility 
and a disparity between socket and prosthesis movement can be seen, 
then pegging can be considered 6 to 12 months after implant 
placement. The time delay is necessary to ensure adequate implant 
vascularization. Magnetic Resonance Imaging with gadolinium 
contrast medium may be useful in assessing vascularity of the implant.  
 Pegging systems exist for both the hydroxyapatite and the 
porous polyethylene implants. Each system involves the placement of a 
post (ie, a peg) into the central implant (Figure 18) along a line 
paralleling what would be the visual axis. A template prepared by the 
ocularist can assist the surgeon in achieving proper centration. A small 
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portion of the post protrudes above the conjunctival tissues and 
engages a corresponding indentation on the posterior surface of the 
prosthesis. In addition to the potential for improved motility, such 
coupling may serve to distribute a portion of the weight of the 
prosthetic to the implant, effectively unweighting the lower eyelid. 
This may, over time, minimize lower-eyelid sag. Although impressive 
results are possible following prosthesis–implant coupling, the patient 
must be prepared to accept the potential complications of the 
procedure. Long-term effects of pegging are not known, but early 
problems include exposure, extrusion, and socket discharge.  
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COMPLICATIONS 
Blepharoptosis 
 Either true or pseudoblepharoptosis18 may follow eye removal. 
True blepharoptosis can be a result of aponeurotic dehiscence, levator 
palpebrae muscle injury, or damage to the innervation of the levator 
palpebrae. These complications may result from the initial trauma or 
the surgical procedure used to remove the eye. Careful preoperative 
assessment is necessary to document a preexisting problem. 
Enucleation surgery, by virtue of visitation to the retrobulbar space, 
has higher potential for damage to the levator palpebrae muscle or the 
orbital branches of the third cranial nerve. Pseudoblepharoptosis can be 
associated with inadequate volume replacement or the shape of the 
prosthetic. An ideal implant replaces most of the globe volume, leaving 
only enough room for an adequately sized prosthesis. Too small an 
implant can create enophthalmos, and the lack of anterior projection 
changes the geometry of the levator palpebrae complex. The ocularist 
can increase the vertical height of the prosthesis or build up its superior 
margin—within the limits of acceptable weight and volume—to help 
correct eyelid position. Too large a prosthesis, though, can decrease 
motility and create lower-eyelid malposition.  
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Lower-Eyelid Malposition and Laxity 
 Both minimizing prosthetic size and coupling the implant to the 
prosthesis decrease the amount of weight that the lower eyelid must 
support. Over time, though, it is not uncommon for the lower eyelid to 
yield to gravitational forces and a lower-eyelid- tightening procedure 
might be necessary. If recurrences of lower-eyelid malposition 
secondary to a large prosthetic occur, it may be necessary to replace 
the orbital implant with one of greater volume.  The increased volume 
of the implant allows the ocularist to fit a smaller prosthesis. 
Enophthalmos 
 As noted above, enophthalmos is usually related to inadequate 
volume replacement at the time of enucleation or evisceration. In cases 
of trauma, with concurrent damage to the bony orbital walls, spherical 
implants alone may be insufficient for volume replacement. Orbital 
fracture repair may be necessary to achieve satisfactory results. 
Socket Contracture 
 One of the more difficult complications to manage is contracture 
of the socket and the associated foreshortening of the fornices. 
Depending on the degree of contracture, the patient may be unable to 
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wear a prosthesis and surgical expansion often requires tissue grafting 
to the mucosa-lined socket.  In removing the eye, every effort should 
be made to preserve Tenon’s capsule and the conjunctiva. Preserving 
these structures can be challenging in serious ocular injuries and may 
necessitate primary dermis fat grafting if insufficient tissue is 
available. Following either enucleation or evisceration, a conformer of 
the largest possible size should be placed into the palpebral fornices as 
a socket maintainer. Patients should be instructed on how to replace the 
conformer should it dislodge and the potential consequences of not 
wearing one for prolonged periods. 
Implant Exposure 
 Tension on the closure of Tenon’s capsule and conjunctiva may 
predispose to wound breakdown and exposure of the implant . A rough 
implant surface (eg, uncovered hydroxyapatite spheres) has also been 
associated with anterior implant exposure and extrusion. Small, stable 
defects of the conjunctiva may be observed. Progressive areas of 
exposure or those associated with infection require intervention. In 
some cases, the anterior projection of the porous implant may be 
reduced, allowing for a tension-free closure of Tenon’s capsule and 
conjunctiva. An electric burr is used to remove portions of the anterior 
implant both to reduce its projection and to expose.  
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SUMMARY 
 Early care  must be definitive, with every possible attempt made 
to preserve vision. In the event that this is not possible, the  
ophthalmologist must be prepared to remove the affected eye. A 
careful decision of evisceration or enucleation should be made 
depending on the indication. In planning, the ophthalmic surgeon must 
identify those essential supplies necessary to provide optimum care. 
Space and weight allowances will limit gear selection. A single implant 
that is suitable for both enucleation and evisceration is ideal. 
Additionally, an implant that allows direct attachment of the 
extraocular muscles will save on the necessity to stock a wrapping 
material such as donor sclera. A selection of 12-mm, 14-mm and  
16-mm implants in the Indian population should be adequate. The 
advantages of stabilization and access to the immune system warrant 
consideration of porous implants. The ophthalmologist should also 
ensure that an adequate supply of socket conformers is available, as the 
freshly operated socket will contract without one.  After a period of six 
weeks the patient should be fitted with a suitable prosthesis, provided 
the socket is healthy and adequate in volume. 
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AIM OF THE STUDY 
 To evaluate a modified evisceration technique employing trans-
scleral quadrisection and implantation in non-infected blind eyes.  
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MATERIALS AND METHODS 
 30 patients with non-infected blind eyes who came to RIOGOH 
between June 2009 and November 2010  
DESIGN 
 A prospective interventional case study 
INCLUSION CRITERIA  
 Painful blind eyes due to anterior staphyloma (Figure 19),  
end-stage  glaucoma (Figure 20), phthisis bulbi. 
EXCLUSION CRITERIA  
 Endophthalmitis, panophthalmitis, intraocular malignancies, 
trauma.  
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INVESTIGATIONS 
 A thorough slit-lamp examination followed by B-scan 
ultrasonography was done to rule out intra-ocular malignancy. In 
doubtful cases, corneal smears or vitreous samples were taken and 
culture-positive cases were excluded from the study. A routine blood 
test including a complete haemogram, blood sugar, bleeding and 
clotting time was done. Blood pressure was checked all patients and 
was gotten under control prior to surgery. Adequate pre-operative 
counselling about the procedure, its necessity and outcome of surgery  
was given. Subsequently, the patients were posted for surgery after 
obtaining informed consent.  
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PROCEDURE (Figures 21-26) 
 A four quadrant peribulbar block was given with 10 ml 
lignocaine mixed with 0.1 ml adrenaline. The patient was painted and 
draped once the block was taken. After placing the lid speculum, 360 
degrees conjunctival peritomy was done at the limbus followed by 
excision of the corneal button. All intraocular contents were scooped 
with an evisceration spoon until bleeding stopped completely and plain 
sclera was seen.  Subsequently, four vertical incisions between each of 
the four recti muscles, i.e, at 1,5,7,11 clock hours were made upto 5 
mm away from the optic disc ,thus cutting the sclera into four petals. A 
16 mm PMMA implant was placed inside (except for the phthisical 
eyes ,for which a 12 mm implant was used) and the vertical petals were 
sutured first with 4-0 prolene. Then, horizontal petals were sutured 
similarly, followed by the conjunctiva which was secured by 
continuous 4-0 prolene sutures. Proper wash with antibiotic and saline 
was given, conformer was placed and bandage was applied.  
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POST-OPERATIVE CARE 
 The patient was treated with systemic and topical antibiotics 
post-operatively. The conformer was removed after 5 days, the patients 
were prescribed antibiotic ointment on discharge and followed-up 
every week in the first month (Figures 27 & 28) every fortnightly in 
the second and once a month for the next four months. A plastic shell 
was placed at the end of 6 weeks to provide adequate cosmesis 
(Figures 29 & 30). 
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OBSERVATION AND ANALYSIS 
 30 patients were included in the study, whose ages ranged from 
14 to 65 years. 20 patients were males and 10 were females. 
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COMPLICATIONS 
Parameter assessed Number Percentage 
Conjunctival dehiscence 0 0% 
Extrusion of implant 0 0% 
Infection 2 6.67 % 
Enophthalmos 0 0% 
Poor motility 2 6.67% 
Poor cosmesis 1 3.33% 
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RESULTS 
 Out of 30 non-infectious cases, 20 (66.7%) had anterior 
staphyloma,8 (26.7%) had absolute glaucoma and 2 (6.6%) had 
phthisis bulbi with uveal prolapse. Post-operatively, 2 (6.67%) patients 
had infection by Staphylococcus aureus, 2 (6.67%) patients had poor 
motility of prosthesis and 1 (3.33%) had a poor cosmetic outcome. 
Rest of the patients had a good cosmetic appearance after placement of 
shell, with good motility and no enophthalmos.The success rate of this 
technique is high but no comparison can be made with other similar 
studies as no data is available. 
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DISCUSSION 
 Eye removal surgery runs contrary to ophthalmologists’ interest 
in preservation of vision. When circumstances necessitate, the 
ophthalmic surgeon must be prepared to intervene and provide the best 
result possible. 
  Evisceration is the removal of the ocular contents with 
preservation of the sclera and in some cases, the cornea. Some patients 
may take comfort in evisceration and equate the retention of the scleral 
shell to keeping the eye. It is the initial surgery that defines a 
successful outcome or, conversely, commits the patient to future 
surgical management of complications arising from an inadequate 
repair. Less-than-optimal surgical technique can lead to subsequent 
procedures to address complications. In this regard, trans-scleral 
quadrisection improves the final outcome of surgery and reduces 
complication rates. 
  Also, the solid spherical implants, either acrylic 
(polymethylmethacrylate) or silicone, are well tolerated, have low 
extrusion rates and are inexpensive. They come at a rate of Rs.150, 
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which is easily affordable by poor patients. Their disadvantages 
include a tendency to migrate within the orbit and decreased motility.  
 An ideal implant, in this case, PMMA, replaces most of the 
globe volume, leaving only enough room for an adequately sized 
prosthesis. Too large an implant (18 mm) limits the ability to fashion a 
prosthesis without imparting a proptotic appearance to the orbit. Too 
small an implant (14 mm) can create enophthalmos. Enophthalmos is 
usually related to inadequate volume replacement at the time of 
enucleation or evisceration.  
 Tension on the closure of Tenon’s capsule and conjunctiva may 
predispose to wound breakdown and exposure of the implant. A rough 
implant surface (Eg, uncovered hydroxyapatite spheres) has also been 
associated with anterior implant exposure and extrusion.  Correct 
technique of suturing with 4 – 0 prolene and the smooth surface of 
PMMA implant reduce the risk of extrusion. 
  Also, injudicious use of antibiotics encourages the emergence of 
resistant bacterial strains and contaminated instruments or gloves in the 
surgical field increase the risk of infection. 
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 Finally, ophthalmologists must be prepared to recognize the 
psychosocial issues associated with eye removal and to treat when 
necessary. Therefore, attention to the final cosmetic outcome is 
indispensable and no surgery is complete in this context if devoid of 
patient satisfaction. 
 Hence, keeping the above mentioned considerations in mind, 
this technique works in terms of easy technique with a low learning 
curve, reduced rates of enophthalmos, extrusion of implant and post-
operative infection.Above all, the motility of the prosthesis and overall 
cosmetic outlook are excellent. 
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CONCLUSION 
 Trans-scleral quadrisection technique of evisceration is excellent 
in  non-infected  eyes, especially in terms of lower complication rate, 
good cosmesis and patient satisfaction. PMMA implant is ideal with 
respect to this study as it is very cheap, easily available and requires no 
special technique of placement in the socket. 
PROFORMA 
 
SERIAL NO.     OP/IP NO. 
NAME AND ADDRESS 
AGE/SEX 
OCCUPATION 
SLIT-LAMP EXAMINATION 
INVESTIGATIONS 
HAEMOGLOBIN 
TOTAL BLOOD COUNT 
DIFFERENTIAL BLOOD COUNT 
ERYTHROCYTE SEDIMENTATION RATE 
BLEEDING TIME 
CLOTTING TIME 
BLOOD SUGAR 
BLOOD PRESSURE 
CORNEAL AND CONJUNCTIVAL SMEAR AND CULTURE 
VITREOUS CULTURE 
B-SCAN 
INDICATION FOR EVISCERATION 
COMPLICATIONS 
 
POST-OPERATIVE FOLLOW-UP 
FIRST MONTH 
   DAY 1,   
   FIRST WEEK, SECOND WEEK,  
   THIRD WEEK, FOURTH WEEK 
 
SECOND MONTH 
   SECOND WEEK, FOURTH WEEK 
THIRD MONTH 
FOURTH MONTH 
FIFTH MONTH 
SIXTH MONTH 
    
OUT COME 
 
 
MASTER CHART 
 
S.NO. NAME AGE/SEX OCC EYE IND 
COMP 
I.E D IN E PM PC 
1 VINOTH KUMAR 28/M TYPIST L AS - - - - - - 
2 BEEBI JAAN 60/F HW R AS - - - - - - 
3 KALAIVANI 14/F STU R AS - - - - - - 
4 SUBHASH 17/M STU L AS - - - - - - 
5 ANAND 22/M STU L PH - - - - - + 
6 SULOCHANA 43/F HW R AG - - - - - - 
7 MURUGESAN 48/M LAB R AS - - - - - - 
8 CHINNAPPAN 39/M LAB R AG - - - - - - 
9 PASUPATHY 50/M TAILOR L AG - - - - - - 
10 RAMALINGAM 38/M TEACHER R AS - - + - + - 
11 RAVI 52/M LAB R AS - - - - - - 
12 VASANTHA 52/F HW R AG - - - - - - 
13 RADHA 58/F HW R AS - - - - - - 
14 ANNAMALAI 28/M LAB R AS - - - - - - 
15 KARTHICK 26/M SK L PH - - - - + - 
 S.NO. NAME AGE/SEX OCC EYE IND 
COMP 
I.E D IN E PM PC 
16 PARVATHY 46/F SERVANT R AG - - - - - - 
17 KAMAKSHI 53/F HW L AS - - - - - - 
18 RAJA 58/M LAB L AG - - - - - - 
19 THANGAPPAN 31/M LAB R AS - - + - - - 
20 SREENIVASAN 48/M ENG R AS - - - - - - 
21 PALANI 63/M LAB R AS - - - - - - 
22 CHITTIBABU 65/M BEGGAR L AG - - - - - - 
23 MANIKANDAN 46/M FARMER R AS - - - - - - 
24 MAGESH 36/M SK L AS - - - - - - 
25 GOVINDAN 58/M FARMER R AG - - - - - - 
26 SARASWATHY 54/F HW L AS - - - - - - 
27 BABYAMMAL 55/F HW L AS - - - - - - 
28 PRAKASH 45/M FARMER R AS - - - - - - 
29 AROCKIASAMY 38/M FARMER L AS - - - - - - 
30 SARALA 52/F HW R AS - - - - - - 
 
KEY TO MASTER CHART 
 
ABBREVIATION EXPANSION 
S.NO. Serial Number 
M/F Male/Female 
OCC Occupation 
IND Indication 
COMP Complication 
I.E. Implant Extrusion 
D Dehiscence of Wound 
IN Infection 
E Enophthalmos 
PM Poor Motility 
PC Poor Cosmesis 
HW Housewife 
LAB Labourer 
STU Student 
ENG Engineer 
SK Shop Keeper 
R/L Right/Left 
AG Absolute Glaucoma 
AS Anterior Staphyloma 
PH Phthisis Bulbi 
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LIST OF SURGERIES PERFORMED 
Sl. 
No. Name Age/Sex 
IP/OP 
No. Eye Diagnosis Surgery 
1. Kasthuri 61/F 493210 L Mature Cataract ECCE with 
PCIOL 
2. Aisha 55/F 493912 R Death due to 
burns 
Enucleation and 
excision of 
corneal button 
3. Sengottayan 72/M 514123 R Pterygium Excision 
4. Thannagi 64/F 522121 L Chronic 
Dacryocystitis 
DCT  
5. Narasimhan 59/M 527643 R Pterygium Excision with 
autograft 
6. Rajagopal 33/M 6739 R Chalazion Excision 
7. Veeralakshmi 42/F 8132 L Upper Lid tear Reconstruction  
8. Noyonika 28/F 8136 R Lower Lid tear Reconstruction 
9. Thamizh 69/F 553946 R Chronic 
Dacryocystitis 
DCT 
10. Yogeswari 19/F 8842 L Pterygium Excision with 
amniotic graft 
11. Rajalakshmi 49/F 554329 R Endophthalmitis Evisceration 
12. Sami 71/M 571869 L Immature 
cataract 
SICS with 
PCIOL 
13. Venugopal 61/M 580042 R Pterygium Excision with 
rotation flap 
14. Radha 38/F 9116 L Lacrimal 
Abscess 
I & D  
15. Renuka 64/F 583264 R Anterior 
Staphyloma 
Evisceration 
with PMMA 
implant 
16. Valasamma 67/F 592743 R Chronic 
Dacryocystitis 
External DCR  
 Sl. 
No. Name Age/Sex 
IP/OP 
No. Eye Diagnosis Surgery 
17. Nagesh 47/M 598615 R Endophthalmitis Intra-vitreal 
injection 
18. Veerasamy 70/M 599123 L Lagophthalmos Tarsorrhaphy 
19. Subburayudu 55/M 600428 L Perforated 
corneal ulcer 
TKP 
20. Lakshminarayanan 50/M 612149 R Perforated 
corneal ulcer 
Hooding 
21. Robin 40/M 659423 R Chronic 
Dacryocystitis 
with fistula 
External DCR 
with 
Fistulectomy 
22. Ammaiyappan 70/M 660212 L Neovascular 
glaucoma 
Cyclocryo- 
therapy 
23. Rajesh 57/M 661430 R POAG  Combined 
surgery 
24. Pughazhendhi 72/M 672456 L Neovascular 
glaucoma 
Combined 
surgery 
25. Murugan 69/M 679913 R Panophthalmitis AC wash 
26. Chinnanayaki 74/F 712462 R Globe rupture Wound 
exploration and 
repair 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1      Different types of pegs used for 
    coupling implant to the prosthesis 
FIGURE 2      Hydroxyapatite implant wrapped in 
    donor sclera 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3    Hydroxyapatite implants  
FIGURE 4      Porous Polyethylene implant with suture  
    needle for the attachment of extra‐ocular 
    muscles
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 5      Interconnecting channels in porous  
    polyethylene implant 
FIGURE 6      Fibrous ingrowth into a porous polyethylene 
    implant 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 7      Implant extrusion 
FIGURE 8      Upper lid entropion with lash ptosis and 
    lower lid ectropion due to improper  
    placement of prothesis in the left eye 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 9 – 15  Procedure of evisceration 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 16     Dermis fat graft 
FIGURE 17      Scleral – covered hydroxyapatite implant 
with open posterior aspect for enhanced 
vascularization and four windows of sclera 
excised for attachment of recti
  
 
 
 
 
FIGURE 18      Pegging of central implant  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 19     Anterior staphyloma
FIGURE 20      Absolute glaucoma 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE   21      Bare sclera after intra‐ocular contents  are 
    scooped out  
FIGURE   22      Intra‐ocular cavity washed with Povidone 
    iodine solution 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE   23      16 mm PMMA implant placed in the intra –
    ocular cavity after the sclera is transected
    into four petals 
FIGURE   24     Petals  sutured with  4 ‐  0 Prolene along the vertical meridian    
  
 
 
 
 
 
 
 
FIGURE   25     Petals  sutured along the horizontal meridian    
FIGURE   26     Conjunctiva  closed with continuous sutures 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURES   27 & 28  Right eye seen one week after evisceration 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE   29       Left eye  seen six weeks after surgery,  prior 
    to the placement of prosthesis  
FIGURE  30    Left eye seen six weeks after surgery, after
    the placement of prosthesis 
